Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pituitary Neoplasms 4Nelson Syndrome 2Multiple Myeloma 2Carcinoma, Hepatocellular 2Carcinoid Tumor 2ACTH Syndrome, Ectopic 2Uveal Melanoma 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Serotonin Syndrome 1Sarcoma, Synovial 1Prostatic Neoplasms 1Prolactin-Producing Pituitary Tumor 1Primary Inoperable Thymoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pituitary ACTH Hypersecretion 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Meningioma 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulinoma 1Hyperinsulinism 1

Interventions

Hydroxyurea 7Bevacizumab 7Everolimus 6lutetium Lu 177 dotatate 4Magnetic Resonance Spectroscopy 4pembrolizumab 3abemaciclib 3Sunitinib 3Imatinib Mesylate 3vistusertib 2gallium Ga 68 dotatate 2arginyllysine 2aldesleukin 2Whole Body Imaging 2Specimen Handling 2Radiotherapy 2Octreotide 2Nivolumab 2Cyclophosphamide 2Amino Acids 290Y-octreotide, DOTA-Tyr(3)- 2vatalanib 1tozuleristide 1sargramostim 1regorafenib 1pasireotide 1neratinib 1fludarabine phosphate 1fludarabine 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Meningioma × pasireotide × Clear all
NCT00813592 2014-06-11

Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma

University of Utah

Phase 2 Terminated
2 enrolled 6 charts
CNS

Meningioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡